Patents Examined by Jose? G. Dees
  • Patent number: 6746680
    Abstract: A cosmetic containing at least 1% by weight of hydrofluoroether having a viscosity of less than 5 mPa·s at 25° C., which is represented by the general formula (1): CnHmF1—O—CxHyFz  (1) wherein n is a number of 1 to 12, m is a number of 0 to 25, 1 is a number of 0 to 11, m+1=2n+1, x is a number of 1 to 12, y is a number of 0 to 25, z is a number of 0 to 11, and y+z=2x+1, provided that m and y are not be simultaneously zero, and 1 and z are not be simultaneously zero, gives no environment disruption, is highly safe for the skin and improves the feeling in use.
    Type: Grant
    Filed: June 13, 2002
    Date of Patent: June 8, 2004
    Assignee: Daikin Industries Ltd.
    Inventors: Masamichi Morita, Motonobu Kubo
  • Patent number: 6703029
    Abstract: Cosmetic or dermatological preparations, which are finely dispersed systems of the oil-in-water or water-in-oil type, comprising 1. an oil phase, 2. an aqueous phase, 3. at least one modified polysaccharide which (a) has both hydrophilic and lipophilic properties, i.e. has amphiphilic character, and is thus dispersible both in water and in oil, and which (b) has no thickening properties, and 4. at most 0.5% by weight of one or more emulsifiers. and also optionally comprising further cosmetic or pharmaceutical auxiliaries, additives and/or active substances.
    Type: Grant
    Filed: January 24, 2001
    Date of Patent: March 9, 2004
    Assignee: Beiersdorf AG
    Inventors: Heinrich Gers-Barlag, Anja Müller
  • Patent number: 6699509
    Abstract: Three solution application method for tattoo removal.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: March 2, 2004
    Inventors: Silvia Melinte, Gavril S. Melinte
  • Patent number: 6669965
    Abstract: A method of treating or preventing atherosclerosis in a mammalian subject comprises: (a) extracting the aliquot of blood from the subject; (b) treating the aliquot of blood ex vivo with at least one stressor selected from the group consisting of an oxidizing agent, ultraviolet radiation and elevated temperature; and (c) administering the aliquot of blood treated in step (b) to the subject. Preferably, the aliquot has a volume of from about 0.01 ml to about 400 ml and is treated simultaneously by ozone gas and ultraviolet radiation at a temperature of from 37-55° C.
    Type: Grant
    Filed: November 9, 1999
    Date of Patent: December 30, 2003
    Assignee: Vasogen Ireland Limited
    Inventor: Anthony E. Bolton
  • Patent number: 6656499
    Abstract: A composition for transdermal and dermal administration of interferon-&agr; is described. The composition is comprised of lipid vesicles including a fatty acylated amino acid and an oil-in-water emulsion. Interferon-&agr; is entrapped in the vesicles.
    Type: Grant
    Filed: November 10, 2000
    Date of Patent: December 2, 2003
    Assignee: PharmaDerm Laboratories, Ltd.
    Inventors: Marianna Foldvari, Sam Attah-Poku
  • Patent number: 6645478
    Abstract: A reshapable hair styling composition comprising at least one (meth)acrylic copolymer comprising: (a) units derived from at least one monomer chosen from (meth)acrylate esters of branched and straight chain alkyl alcohols, (b) units derived from at least one monomer chosen from (meth)acrylate esters of saturated and unsaturated cyclic alcohols containing 6 to 20 carbon atoms, (c) optionally units derived from at least one monomer chosen from hydrophilic monomers, and (d) optionally units derived from at least one monomer other than (a), (b), and (c) monomers, wherein said at least one (meth)acrylic copolymer comprises units derived from at least four different monomers and wherein said composition provides a reshapable effect.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: November 11, 2003
    Assignee: L'Oreal S.A.
    Inventors: Isabelle Rollat, Henri Samain, Olivier Morel
  • Patent number: 6645531
    Abstract: The present invention is directed to pharmaceutical compositions that include a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which has a first valence state and at least one of which has a second, different valence state. Preferred compounds include Bi(III,V) oxide, Co(II,III) oxide, Cu(I,III) oxide, Fe(II,III) oxide, Mn(II,III) oxide, and Pr(III,IV) oxide, and optionally Ag(I,III) oxide. These compounds may be in a crystalline state having metallic cations of two different valences, or electronic states, in the inorganic crystal. In addition, the invention relates to methods for prevention, management, or treatment of a condition using these compounds or pharmaceutical compositions including the same.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: November 11, 2003
    Assignee: Marantech Holding LLC
    Inventor: Marvin S. Antelman
  • Patent number: 6641800
    Abstract: Pressurized aerosol composition for administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer soluble in the liquefied hydrofluoroalkane which is selected from polymers including recurring amide containing structural units, copolymers of amide containing units and carboxylic acid ester units, polyvinylacetate and acrylic acid/methacrylic acid ester copolymers.
    Type: Grant
    Filed: July 13, 2000
    Date of Patent: November 4, 2003
    Assignee: Fisons Ltd.
    Inventors: Suresh N Mistry, Mark Gibson
  • Patent number: 6642205
    Abstract: A pharmaceutical compound and a process for making the compound is provided where the compound includes a therapeutic agent, a spacer and a galactose, the spacer being covalently linked to the therapeutic agent at a first site on the spacer and covalently linked to the galactose by an ether bond at a second site on the spacer to form a conjugate. The conjugate may be used to treat a subject suffering from a medical condition, so as to reduce the side effects associated with the therapeutic agent by administering an effective dose of the conjugate to the subject so that the side effects in the subject are less then they would have been with the unconjugated therapeutic agent.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: November 4, 2003
    Assignee: Pro-Pharmaceuticals, Inc.
    Inventors: Anatole Klyosov, David Platt
  • Patent number: 6632420
    Abstract: A clear personal care composition includes water, a volatile silicone, and a silicone polyether having a molecular weight greater than 1000 and an HLB greater than 4. The composition may be, for example, an antiperspirant or deodorant composition.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: October 14, 2003
    Assignee: The Gillette Company
    Inventors: Raymond W. Cen, David T. Callaghan
  • Patent number: 6630458
    Abstract: Use of a composition comprising chitosan in combination with a polysaccharide selected from heparin, heparan sulphate and dextran sulphate, as an active component in a solvent, for the manufacture of a teat dipping solution for lactating animals, particularly cows. The invention also relates to a process for prophylactic or wound healing treatment of lactating animals, particularly cows, against mastitis.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: October 7, 2003
    Assignee: Medicarb AB
    Inventors: Olle Larm, Marcus Back
  • Patent number: 6630136
    Abstract: A cosmetic or dermatological composition for treating keratinous material, particularly human hair, including a cosmetically or dermatologically acceptable medium containing at least one silcone-grafted polymer with a polysiloxane backbone grafted by non-silicone organic monomers and at least one amphiphilic polymer comprising at least one fatty chain and at least one hydrophilic unit. Such compositions are particularly suitable for use as rinsable or non-rinsable products for washing and conditioning hair, hair setting of hair styling.
    Type: Grant
    Filed: June 8, 2000
    Date of Patent: October 7, 2003
    Assignee: L'Oreal
    Inventors: Claude Dubief, Christine Dupuis
  • Patent number: 6630151
    Abstract: A process of preparing a composition of enhanced viscosity comprises adding to a liquid oil, a high molecular weight solid monocarboxylic acid having a number average molecular weight of less than 3,000. The resulting composition is considerably more viscous than the compositions of the prior art and has particular applicability in the cosmetic and pharmaceutical industries.
    Type: Grant
    Filed: May 27, 1997
    Date of Patent: October 7, 2003
    Assignee: Baker Hughes Incorporated
    Inventors: Christopher J. Tarletsky, Richard J. Nadolsky, Shawn L. Myers
  • Patent number: 6630156
    Abstract: The present invention relates to a process for preparing biodegradable microspheres containing physiologically active agents. Particularly, the present invention relates to the process comprised the following steps (1) to prepare a polymer solution containing physiologically active agents wherein a biodegradable polymer is dissolved in a water-soluble organic solvent and physiologically active agents are dissolved or suspended to it; (2) to form a O/O type emulsion by emulsifying the polymer solution into a water soluble alcohol which contains an emulsion stabilizer; and (3) to extract the organic solventS and alcohol by adding the emulsion into a neutral or an alkaline aqueous solution to educe the microspheres. The process of the present invention is effective for producing the microspheres having a uniform size which arm congenital to a living body and has an excellent inclusion efficiency. So, the microspheres prepared by the process of the present invention are used for a drug delivery system.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: October 7, 2003
    Assignee: Samyang Corporation
    Inventors: Min Hyo Seo, Jae Yong Lee, Jee Hyang Kim
  • Patent number: 6627216
    Abstract: The present invention provides novel “patch in a bottle” technology in which a fluid composition, e.g., an aerosol spray, is applied onto a surface as a fluid, but then dries to form a covering element, such as a patch, having a tack free outer surface covering an underlying adhesive that helps adhere the patch to the substrate. The fluid compositions have a unique chemical formulation that allows such composite patches to form in situ. Specifically, the fluid compositions include a tacky component, such as an adhesive, and a film-forming, non-tacky component. The non-tacky and tacky components are selected to be immiscible with each other so that the components undergo phase separation as the fluid composition dries.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: September 30, 2003
    Assignee: 3M Innovative Properties Company
    Inventors: Patricia J. Andolino Brandt, Charles M. Leir, David J. Wirtanen
  • Patent number: 6627603
    Abstract: A method for the controlled release of an active principle contained in a multiple water-in-oil-in-water emulsion characterized in that the multiple emulsion comprises an invert emulsion Ei with an aqueous phase A1 containing at least a hydrophilic active principle. The emulsion Ei is dispersed in the form of direct emulsion droplets Ed, in a continuous aqueous phase A2, with the two emulsions Ed and Ei stabilized by at least a surfactant, present in their respective continuous phases. The multiple emulsion is brought in the presence of an effective amount of an agent for transforming it into a direct emulsion and induce the release of the active principle, contained in the aqueous phase A1 of emulsion Ei, in the aqueous phase A2.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: September 30, 2003
    Assignee: Centre National de la Recherche Scientifiquue (C.N.R.S.)
    Inventors: Jérôme Bibette, Marie-Françoise Ficheux, Fernando Leal Calderon, Lida Bonnakdar
  • Patent number: 6627178
    Abstract: Provided by the invention are systems for applying diaper rash treatment compositions to a selected skin treatment area without the need for the person administering the treatment to directly contact the composition or the skin of the patient. Application of the diaper rash treatment composition is accomplished by forming the composition into a mist or spray using an atomizing spray dispenser.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: September 30, 2003
    Inventor: Garret D. Cawthon
  • Patent number: 6623728
    Abstract: Cosmetic skin care methods comprising applying to the skin compositions containing gum mastic. The inventive compositions provide control of sebum secretion from sebocytes, improved oil control and improved skin feel, prevent shine and stickiness, while also providing anti-aging benefits which results in reduced appearance of wrinkles and aged skin, improved skin color, treatment of photoaged skin, improvement in skin's radiance and clarity and finish, and an overall healthy and youthful appearance of the skin.
    Type: Grant
    Filed: June 1, 2001
    Date of Patent: September 23, 2003
    Assignee: Unilever Home & Personal Care USA Division of Conopco, Inc.
    Inventors: Bijan Steven Harichian, John Steven Bajor, Laura Rose Palanker
  • Patent number: 6623763
    Abstract: A pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system, for the release of the active substance 17-&bgr;-estradiol, contained therein in dissolved form being between its saturation concentration in equilibrium with a gas phase of less than 10% relative air humidity and its saturation concentration in equilibrium with a gas phase of more than 90% relative air humidity, in all matrix levels and, if present, also in an adhesive layer, characterized in that the estradiol quantity contained in in the preparation amounts to at least three times the saturation solubility measured at 95% relative air humidity, and that the air enclosed in the package is adjusted to a relative air humidity between 5% and below 0.5%.
    Type: Grant
    Filed: June 19, 2001
    Date of Patent: September 23, 2003
    Assignee: LTS Lohmann Therape-System AG
    Inventors: Bodo Asmussen, Michael Horstmann
  • Patent number: 6620846
    Abstract: A method of treating living tissue includes applying to living tissue a biocompatible adhesive composition containing at least one alkyl ester cyanoacrylate monomer and a polymerization initiator or accelerator, wherein the polymerization initiator or accelerator is a quaternary amine.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: September 16, 2003
    Assignee: Closure Medical Corporation
    Inventors: Jerry Y. Jonn, John Bobo, Julian Quintero, Jon P. Moseley